Scholarly article on 4-chloro-trityl bromide 856204-48-3 from Journal of the American Chemical Society p. 4059,4065

DOI: 10.1021/ja01349a033

Source and publish data:

Journal of the American Chemical Society p. 4059,4065 (1932)

Update date:2022-08-05

Topics:

Authors:

Schoepfle

Trepp Trepp

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1021/ja01349a033

Full text of DOI:10.1021/ja01349a033

Products guided by the article

Product name:4-chloro-trityl bromide

Cas No:856204-48-3

R&D Labs maybe for 856204-48-3

Jinan Boss Chemical Industry Co., Ltd.【revoke the business license】

website:http://www.chemboss.com.cn

Contact:+86-531-58591595

Address:No2.Hualong Road, Jinan, China
JiangXi Hong Run Chemical Co., Ltd

Contact:+86-0791-88521351

Address:XingHuo industrial zone in YongXiu county
SOGA ENTERPRISES ASIA GROUP

Contact:+86-633-8332928

Address:No.1,Huanghai Yilu.Rizhao,Shandong
ZhangJiaGang YaRui Chemical Co.,Ltd.

Contact:0512-58360968

Address:China JiangSu Province Zhang Jia Gang City YangShe Oriental Plaza Building 10 B307
Jinan Aery Pharmaceutical Co,.Ltd

Contact:+8653181263406

Address:1-1916,Building1 Fenghuang SOHO,Fenghuang Road,High-tech Zone,Jinan,Shandong

Relevant to this article

Stereoselective synthesis of β-hydroxyphenylalanines using imino 1,2-Wittig rearrangement of hydroximates

Doi:10.1248/cpb.53.355
(2005)
STEREOCONTROLLED SYNTHESIS OF STEROID SIDE CHAIN; STEREOSELECTIVE SYNTHESES OF CHOLESTEROL AND 25-HYDROXYCHOLESTEROL

Doi:10.1016/S0040-4039(00)85693-2
(1982)
BiCl₃-modified perlite as an effective catalyst for selective organic transformations: a green protocol

Doi:10.1007/s11164-019-03836-x
(2019)
Doi:10.1002/hlca.19530360218
(1953)
Reactions of K₂[Fe(CO)₃(PPh₃)]: Reductive Sb-Sb coupling with Ph₂SbCl to form trans-[Fe(CO) ₃(PPh₃)(Sb₂Ph₄)] and salt metathesis with Me₃SbCl₂ to yield trans-[Fe(CO)₃(PPh ₃)(SbMe₃)]

Doi:10.1002/ejic.200400683
(2005)
Structure requirements for anaerobe processing of azo compounds: Implications for prodrug design

Doi:10.1016/j.bmcl.2012.10.014
(2012)

Article Doi

DOI: 10.1021/ja01349a033